Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.31 |
| ▸ | CPT2 | P23786 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | HMGCR | P04035 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL1896978 | 0.97 | EGFR (0.31) | EGFRLMNAHSD17B10GAAFFAR1 | |
| SCHEMBL2339066 | 0.85 | ALDH1A1 (0.34) | FFAR1CPT2TDP1CHRM1ADRA1A | |
| SCHEMBL33483 | 0.83 | GAA (0.32) | GAA | |
| Ammonia Solution, Strong SCHEMBL2279603 | 0.83 | ALDH1A1 (0.33) | FFAR1CPT2TDP1CHRM1ADRA1A | |
| SCHEMBL3692526 | 0.82 | ALDH1A1 (0.43) | LMNAHSD17B10GAAFFAR1CPT2 | |
| SCHEMBL18877590 | 0.81 | FFAR1 (0.40) | FFAR1CPT2TDP1 | |
| Ammonia Solution, Strong SCHEMBL2277898 | 0.81 | TDP1 (0.35) | FFAR1CPT2TDP1 | |
| SCHEMBL607857 | 0.81 | ALDH1A1 (0.41) | EGFRLMNAHSD17B10GAA | |
| SCHEMBL16754717 | 0.80 | — | — | |
| SCHEMBL14762934 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230382940-A1 | ANTIVIRAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | GILEAD SCIENCES, INC. | 2023-11-30 | — | — | US | disclosed |
| WO-2023168254-A1 | ANTIVIRAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | GILEAD SCIENCES, INC. (US) | 2023-09-07 | — | — | WO | disclosed |
| CN-110249470-A | For alkali metal-sulphur system secondary cell electrolyte and alkali metal-sulphur system secondary cell | 学校法人关西大学 | 2019-09-17 | — | — | CN | disclosed |
| CN-106133986-B | Electrolyte and electrochemical device | 大金工业株式会社 | 2019-07-09 | — | — | CN | disclosed |
| CN-109301162-A | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY USING SAME | 三菱化学株式会社 | 2019-02-01 | — | — | CN | disclosed |
| CN-105074994-B | Nonaqueous electrolyte solution and nonaqueous electrolyte battery using same | 三菱化学株式会社 | 2018-10-19 | — | — | CN | disclosed |
| US-20180191026-A1 | PROTECTIVE LAYER HAVING IMPROVED CONTACTING FOR LITHIUM CELLS AND/OR LITHIUM BATTERIES | ROBERT BOSCH GMBH (DE) | 2018-07-05 | — | — | US | disclosed |
| CN-107078352-A | Nonaqueous electrolyte solution and nonaqueous electrolyte secondary battery using same | 三菱化学株式会社 | 2017-08-18 | — | — | CN | disclosed |
| CN-105555381-B | Method for treating mixed solution | 三和油化工业株式会社 | 2017-05-17 | — | — | CN | disclosed |
| CN-106133986-A | Electrolyte and electrochemical device | 大金工业株式会社 | 2016-11-16 | — | — | CN | disclosed |
| EP-0680949-A2 | O-(oxyimino)ethyl-cyclohexenone oximethers and their use as herbicides | BASF AKTIENGESELLSCHAFT (DE) | 1995-11-08 | — | — | EP | disclosed |
| EP-0666254-A1 | 2-Aroylcydohexanediones, process for their preparation and their use as herbicide or as plant growth regulating agent | BASF AKTIENGESELLSCHAFT (DE) | 1995-08-09 | — | — | EP | disclosed |
| EP-0625976-A1 | MIXTURES OF OPTICALLY ACTIVE CYCLOHEXENONE OXIME ETHERS, PROCESS AND INTERMEDIATE PRODUCTS FOR THEIR PRODUCTION AND THEIR USE AS HERBICIDES. | BASF AG (DE) | 1994-11-30 | — | — | EP | disclosed |
| EP-0625975-A1 | CYCLOHEXENONE OXIME ETHERS, PROCESS FOR MAKING THEM AND THEIR USE AS HERBICIDES. | BASF AG (DE) | 1994-11-30 | — | — | EP | disclosed |
| EP-0600717-A1 | Phenoxyalkylamines, -pyrrolidines and -piperidines for the treatment and prevention of circulatory diseases and psychosis | SANKYO COMPANY LIMITED (JP) | 1994-06-08 | — | — | EP | disclosed |
| WO-1994004489-A1 | CYCLOHEXENONOXIME ETHERS, THEIR PREPARATION AND THEIR USE | BASF AKTIENGESELLSCHAFT (DE) | 1994-03-03 | — | — | WO | disclosed |
| WO-1993016063-A1 | CYCLOHEXENONE OXIME ETHERS, PROCESS FOR MAKING THEM AND THEIR USE AS HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1993-08-19 | — | — | WO | disclosed |
| WO-1993016061-A1 | MIXTURES OF OPTICALLY ACTIVE CYCLOHEXENONE OXIME ETHERS, PROCESS AND INTERMEDIATE PRODUCTS FOR THEIR PRODUCTION AND THEIR USE AS HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1993-08-19 | — | — | WO | disclosed |
| WO-1993011669-A1 | USE OF 3-PHENYLURACIL DERIVATIVES FOR THE DESICCATION AND ABSCISSION OF PLANT PARTS | BASF AKTIENGESELLSCHAFT (DE) | 1993-06-24 | — | — | WO | disclosed |
| US-5082964-A | Selective acetylcholinesterase inhibitors and methods of making and using same | LEHIGH UNIVERSITY (US) | 1992-01-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230382940-A1 | ANTIVIRAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | EIF2AK2, MAVS, ZC3HAV1 | EGFR 4365/4885LMNA 2192/4885HSD17B10 3073/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.